The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Chen, Rongxin ^a,b   Cui, Jiefeng ^a,b   Xu, Changde ^c   Xue, Tongchun ^a,b   Guo, Kun ^a,b   Gao, Dongmei ^a,b   Liu, Yinkun ^a,b   Ye, Shenglong ^a,b   Ren, Zhenggang ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Department of Nuclear Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PATHOLOGY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84864977943     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1836-7     Document Type: Article

References (41)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin. 55 74 108 15761078 10.3322/canjclin.55.2.74
2. HB El-Serag KL Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology. 132 2557 2576 17570226 10.1053/j.gastro.2007.04.061 1:CAS:528:DC%2BD2sXnvFOgsrw%3D
3. J Bruix JM Llovet 2009 Major achievements in hepatocellular carcinoma Lancet. 373 614 616 19231618 10.1016/S0140-6736(09)60381-0
4. ZY Tang SL Ye YK Liu LX Qin HC Sun QH Ye, et al. 2004 A decade's studies on metastasis of hepatocellular carcinoma J Cancer Res Clin Oncol. 130 187 196 14685850 10.1007/s00432-003-0511-1
5. K Hao JM Luk NP Lee M Mao C Zhang MD Ferguson, et al. 2009 Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters BMC Cancer 9 389 19886989 10.1186/1471-2407-9-389
6. LX Qin ZY Tang 2004 Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature J Cancer Res Clin Oncol. 130 497 513 15205947 10.1007/s00432-004- 0572-9 1:CAS:528:DC%2BD2cXmt1Krtb0%3D
7. Y Sakamoto K Mafune M Mori T Shiraishi H Imamura M Mori, et al. 2000 Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma Int J Oncol. 17 237 243 10891530 1:CAS:528:DC%2BD3cXls1KltbY%3D
8. A Jezierska T Motyl 2009 Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review Med Sci Monit 15 RA32 RA40 19182722 1:CAS:528:DC%2BD1MXksVOrurg%3D
9. Q Zhang X Chen J Zhou L Zhang Q Zhao G Chen, et al. 2006 CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients Cancer Biol Ther. 5 808 814 16775432 10.4161/cbt.5.7.2754 1:CAS:528:DC%2BD28XhtVOju7%2FE
10. F Bagnoli VM Oliveira MA Silva GC Taromaru JF Rinaldi T Aoki 2010 The interaction between aromatase, metalloproteinase 2, 9 and cd44 in breast cancer Rev Assoc Med Bras. 56 472 477 20835647 10.1590/S0104-42302010000400023
11. HC Yeh SM Lin MF Chen TL Pan PW Wang CT Yeh 2010 Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma Hepatogastroenterology. 57 98 102 20422881 1:CAS:528: DC%2BC3cXmtVCit78%3D
12. G Giannelli C Bergamini F Marinosci E Fransvea M Quaranta L Lupo, et al. 2002 Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma Int J Cancer. 97 425 431 11802202 10.1002/ijc.1635 1:CAS:528:DC%2BD38XkvFehsA%3D%3D
13. JS Chen Q Wang XH Fu XH Huang XL Chen LQ Cao, et al. 2009 Involvement of PI3 K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9 Hepatol Res. 39 177 186 19208038 10.1111/j.1872-034X.2008.00449.x 1:CAS:528:DC%2BD1MXjvVygsrk%3D
14. N Hah ST Lee 2003 An absolute role of the PKC-dependent NF-kappaB activation for induction of MMP-9 in hepatocellular carcinoma cells Biochem Biophys Res Commun. 305 428 433 12745093 10.1016/S0006-291X(03)00788-5 1:CAS:528:DC%2BD3sXjs1erurc%3D
15. S Arii M Mise T Harada M Furutani S Ishigami M Niwano, et al. 1996 Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential Hepatology. 24 316 322 8690399 10.1002/hep.510240206 1:STN:280:DyaK28zhvFCksQ%3D%3D
16. P Zhao W Zhang J Tang XK Ma JY Dai Y Li, et al. 2010 Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147 Cancer Sci. 101 387 395 20047591 10.1111/j.1349-7006.2009.01420.x 1:CAS:528:DC%2BC3cXivFeqtLw%3D
17. K Kohga T Tatsumi T Takehara H Tsunematsu S Shimizu M Yamamoto, et al. 2010 Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma J Hepatol. 52 872 879 20395004 10.1016/j.jhep.2009.12.030 1:CAS:528:DC%2BC3cXmsVejurc%3D
18. A Miyoshi Y Kitajima K Sumi K Sato A Hagiwara Y Koga, et al. 2004 Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells Br J Cancer. 90 1265 1273 15026811 10.1038/sj.bjc.6601685 1:CAS:528:DC%2BD2cXitV2rsL0%3D
19. T Torimura T Ueno M Kin R Harada T Nakamura T Kawaguchi, et al. 2001 Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins Hepatology. 34 62 71 11431735 10.1053/jhep.2001.25546 1:CAS:528:DC%2BD3MXltlKjs70%3D
20. J Tang J Cui R Chen K Guo X Kang Y Li, et al. 2011 A three-dimensional cell biology model of human hepatocellular carcinoma in vitro Tumour Biol. 32 469 479 21140254 10.1007/s13277-010-0140-7
21. Q Gao XY Wang SJ Qiu I Yamato M Sho Y Nakajima, et al. 2009 Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma Clin Cancer Res. 15 971 979 19188168 10.1158/1078-0432.CCR-08-1608 1:CAS:528:DC%2BD1MXht1Ontr8%3D
22. O Morimoto H Nagano M Sakon Y Fujiwara T Yamada H Nakagawa, et al. 2003 Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas J Hepatol. 39 215 221 12873818 10.1016/S0168-8278(03) 00233-2 1:CAS:528:DC%2BD3sXlsVWlurc%3D
23. K Takayasu S Arii I Ikai M Omata K Okita T Ichida, et al. 2006 Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology. 131 461 469 16890600 10.1053/j.gastro.2006.05.021 1:CAS:528:DC%2BD28XpsFyks7Y%3D
24. N Johansson M Ahonen VM Kahari 2000 Matrix metalloproteinases in tumor invasion Cell Mol Life Sci. 57 5 15 10949577 10.1007/s000180050495 1:CAS:528:DC%2BD3cXhslOrsrs%3D
25. K Kessenbrock V Plaks Z Werb 2010 Matrix metalloproteinases: regulators of the tumor microenvironment Cell. 141 52 67 20371345 10.1016/j.cell.2010.03. 015 1:CAS:528:DC%2BC3cXlsVSgtb4%3D
26. P Vihinen R Ala-aho VM Kahari 2005 Matrix metalloproteinases as therapeutic targets in cancer Curr Cancer Drug Targets. 5 203 220 15892620 10.2174/1568009053765799 1:CAS:528:DC%2BD2MXksFKktr0%3D
27. P Vihinen VM Kahari 2002 Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int J Cancer. 99 157 166 11979428 10.1002/ijc.10329 1:CAS:528:DC%2BD38XivFyrsr4%3D
28. P Yang W Yuan J He J Wang L Yu X Jin, et al. 2009 Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis Hepatol Res. 39 1169 1177 19788698 10.1111/j.1872-034X.2009.00563.x
29. D Nart B Yaman F Yilmaz M Zeytunlu Z Karasu M Kiliç 2010 Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation Liver Transpl. 16 621 630 20440771
30. TW Chung YC Lee CH Kim 2004 Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3 K/AKT pathways: involvement of invasive potential FASEB J. 18 1123 1125 15132991 10.1096/fj.04-2126com 1:CAS:528:DC%2BD2cXlslKktr8%3D
31. M Maatta Y Soini A Liakka H Autio-Harmainen 2000 Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis Clin Cancer Res. 6 2726 2734 10914717 1:CAS:528:DC%2BD3cXlslent7Y%3D
32. M Watari H Watari ME DiSanto S Chacko GP Shi JF Strauss III 1999 Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells Am J Pathol. 154 1755 1762 10362800 10.1016/S0002-9440(10)65431-4 1:CAS:528:DyaK1MXjvFGrt7Y%3D
33. S Sawada K Murakami J Murata K Tsukada I Saiki 2001 Accumulation of extracellular matrix in the liver induces high metastatic potential of hepatocellular carcinoma to the lung Int J Oncol. 19 65 70 11408924 1:STN:280:DC%2BD3MzksFCitQ%3D%3D
34. JR Kim CH Kim 2004 Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells Int J Biochem Cell Biol. 36 2293 2306 15313474 10.1016/j.biocel.2004.04.022 1:CAS:528:DC%2BD2cXmslOitbo%3D
35. TW Chung SK Moon YC Lee JG Kim JH Ko CH Kim 2002 Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells Arch Biochem Biophys. 408 147 154 12464265 10.1016/S0003-9861(02)00522-2 1:CAS:528:DC%2BD38XpsF2lu78%3D
36. QH Ye LX Qin M Forgues P He JW Kim AC Peng, et al. 2003 Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med. 9 416 423 12640447 10.1038/nm843 1:CAS:528:DC%2BD3sXisVOmu7o%3D
37. V Takafuji M Forgues E Unsworth P Goldsmith XW Wang 2007 An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma Oncogene. 26 6361 6371 17452979 10.1038/sj.onc.1210463 1:CAS:528: DC%2BD2sXhtV2is73K
38. XN Ji SL Ye Y Li B Tian J Chen DM Gao, et al. 2003 Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials J Cancer Res Clin Oncol. 129 556 564 12942314 10.1007/s00432-003-0475-1
39. A Hayasaka N Suzuki N Fujimoto S Iwama E Fukuyama Y Kanda, et al. 1996 Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma Hepatology. 24 1058 1062 8903375 10.1002/hep.510240513 1:STN:280:DyaK2s%2FmtVensg%3D%3D
40. KJ Wu J Zeng GD Zhu LL Zhang D Zhang L Li, et al. 2009 Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression Acta Pharmacol Sin. 30 1162 1168 19578386 10.1038/aps.2009.94 1:CAS:528:DC%2BD1MXpsVejtrg%3D
41. HA Kenny E Lengyel 2009 MMP-2 functions as an early response protein in ovarian cancer metastasis Cell Cycle. 8 683 688 19221481 10.4161/cc.8.5.7703 1:CAS:528:DC%2BD1MXlvFWjurs%3D